{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:53:06Z","timestamp":1795042386328,"version":"4.10.2"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.autrev.2018.12.004","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T12:00:33Z","timestamp":1549886433000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus"],"prefix":"10.1016","volume":"18","author":[{"given":"Nancy P.","family":"Duarte-Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca L.","family":"Ortiz-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.12.004_bb0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus\u2014a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2018.12.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/715190","article-title":"Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus","volume":"2012","author":"Yu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2018.12.004_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurological manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2018.12.004_bb0025","series-title":"Chapter 28 \u2013 Pathogenesis of the nervous system","volume":"vol. 6","author":"Aranow","year":"2013"},{"key":"10.1016\/j.autrev.2018.12.004_bb0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/138161208799316401","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach","volume":"14","author":"Sanna","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2018.12.004_bb0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","article-title":"Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria","volume":"12","author":"Sciascia","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.12.004_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.12.004_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/0961203308090112","article-title":"Lupus and the central nervous system","volume":"17","author":"Huizinga","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.12.004_bb0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.berh.2005.04.003","article-title":"Management of neuropsychiatric lupus","volume":"19","author":"Hanly","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0065","series-title":"Dubois' Lupus erythematosus and related syndromes","author":"Wallace","year":"2013"},{"key":"10.1016\/j.autrev.2018.12.004_bb0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0961203308090017","article-title":"Neuropsychiatric lupus and infectious triggers","volume":"17","author":"Zandman-Goddard","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.12.004_bb0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00702-005-0375-4","article-title":"Blood-brain barrier dysfunction and recovery","volume":"113","author":"de Boer a","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.autrev.2018.12.004_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.autrev.2018.12.004_bb0090","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1471-4159.2011.07490.x","article-title":"C5a\/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-\u03baB","volume":"119","author":"Jacob","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2018.12.004_bb0095","first-page":"93","article-title":"Blood-brain barrier transport of cytokines","volume":"6","author":"W A","year":"2007","journal-title":"NeuroImmune Biol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00367","article-title":"TWEAK and Fn14 in the neurovascular unit","volume":"4","author":"Yepes","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00484","article-title":"Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 pathway","volume":"4","author":"Stock","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.12.004_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-10-9","article-title":"TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier","volume":"10","author":"Stephan","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2018.12.004_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","article-title":"Complement and blood-brain barrier integrity","volume":"61","author":"Jacob","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00060-7","article-title":"Complement component anaphylatoxins upregulate chemokine expression by human astrocytes","volume":"537","author":"Jauneau","year":"2003","journal-title":"FEBS"},{"key":"10.1016\/j.autrev.2018.12.004_bb0130","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.09-138834","article-title":"C5a alters blood-brain barrier integrity in experimental lupus","volume":"24","author":"Jacob","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2018.12.004_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/imm.12489","article-title":"C5a alters blood-brain barrier integrity in a human in vitro model of lupus","volume":"146","author":"Mahajan","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2018.12.004_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1046-2023(02)00359-6","article-title":"Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood \u2013 brain barrier","volume":"29","author":"Eugenin","year":"2003","journal-title":"Methods"},{"key":"10.1016\/j.autrev.2018.12.004_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-5728(03)00262-5","article-title":"Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice","volume":"142","author":"Zameer","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0150","first-page":"130","article-title":"Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats","volume":"96","author":"Shigemori","year":"2006","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.autrev.2018.12.004_bb0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ncprheum0726","article-title":"Neuropsychiatric lupus erythematosus reconsidered","volume":"4","author":"Sanchez-Guerrero","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjp.0706400","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"Lucas","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0361-9230(01)00428-2","article-title":"Cytokines and the central nervous system","volume":"54","author":"Sz\u00e9lenyi","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2018.12.004_bb0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2009.11.015","article-title":"Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies","volume":"37","author":"Loftis","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.autrev.2018.12.004_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145702003103","article-title":"The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans","volume":"5","author":"Wichers","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0185","first-page":"83","article-title":"Cytokines for psychologists: implications of bidirectional immune-to- brain communication for understanding behavior, mood, and cognition","volume":"105","author":"Maier","year":"1998","journal-title":"T-Cell B-Cell"},{"key":"10.1016\/j.autrev.2018.12.004_bb0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.1993.73.3.489","article-title":"Peptides and blood-brain barrier transport","volume":"73","author":"Ermisch","year":"1993","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2018.12.004_bb0195","first-page":"133","article-title":"Neuromodulative actions of cytokines","volume":"63","author":"Blatteis","year":"1990","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.autrev.2018.12.004_bb0200","series-title":"Role of the OVLT in the febrile response to circulating pyrogens","first-page":"409","volume":"vol. 91","author":"Blatteis","year":"1992"},{"key":"10.1016\/j.autrev.2018.12.004_bb0205","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S1567-5769(01)00129-1","article-title":"Factors modifying the migration of lymphocytes across the blood \u2013 brain barrier","author":"Brown","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0210","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1523\/JNEUROSCI.18-22-09471.1998","article-title":"Activation of vagal afferents after intravenous injection of interleukin-1\u2424: role of endogenous prostaglandins","volume":"18","author":"Ek","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2018.12.004_bb0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","article-title":"Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study","volume":"28","author":"Hirohata","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0220","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0225","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.11279","article-title":"Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement","volume":"48","author":"Trysberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0230","first-page":"2010","article-title":"Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6)","volume":"34","author":"Katsumata","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0235","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","article-title":"Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms","volume":"10","author":"George-Chandy","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.12.004_bb0240","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/03009742.2010.550900","article-title":"Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus","volume":"40","author":"Hopia","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0245","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4049\/jimmunol.182.2.1192","article-title":"Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"182","author":"Santer","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/096120330000900704","article-title":"Tarkowski a. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement","volume":"9","author":"Trysberg","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.12.004_bb0255","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1191\/0961203303lu472sr","article-title":"The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles","volume":"12","author":"J\u00f6nsen","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.12.004_bb0260","first-page":"449","article-title":"Losing your nerve? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat. Rev."},{"key":"10.1016\/j.autrev.2018.12.004_bb0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/glia.1101","article-title":"Basic principles of immunological surveillance of the normal central nervous system","volume":"124","author":"Hickey","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.autrev.2018.12.004_bb0270","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4049\/jimmunol.161.2.692","article-title":"Antigen-dependent Intrathecal antibody synthesis in the Normal rat brain: tissue entry and local retention of antigen-specific B cells","author":"Knopf","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-loyo","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.12.004_bb0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2012.01137.x","article-title":"A model for lupus brain disease","volume":"248","author":"Diamond","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2018.12.004_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rdc.2009.12.007","article-title":"Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus","volume":"36","author":"Aranow","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2018.12.004_bb0290","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2018.12.004_bb0295","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.12.004_bb0300","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1152\/ajpheart.00520.2003","article-title":"Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor","volume":"285","author":"Sharp","year":"2003","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0305","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.37745","article-title":"IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells","volume":"65","author":"Yoshio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0310","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.12.004_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity: antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.12.004_bb0320","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0325","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.12.004_bb0330","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/art.1780290806","article-title":"Clinical and serologic associations of the antiribosomal P protein antibody","volume":"29","author":"Bonfa","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.12.004_bb0340","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.12.004_bb0345","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI115707","article-title":"Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells","volume":"89","author":"Koren","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.12.004_bb0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/jaut.1998.0219","article-title":"Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins","author":"Reichlin","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.12.004_bb0355","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.159.4.2033","article-title":"Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture 1","volume":"159","author":"Koscec","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.12.004_bb0360","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:03Z","timestamp":1761599643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1568997219300369"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.12.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}